Neither <i>KIT</i> nor <i>PDGFRA</i> mutations were detected by Sanger sequencing; however, next-generation sequencing (NGS) identified an <i>FGFR2-KIAA1217</i> gene fusion in the tumor tissue. The gene discussed is FGFR2; the disease is neoplasm.